Here's Why Ziopharm Oncology Fell as Much as 14.0% Today

Shares of Ziopharm Oncology (NASDAQ: ZIOP) fell 14% today after the company announced and priced a public stock offering. The business will sell up to 32 million shares of common stock at $3.25 apiece, which could generate gross proceeds of up to $104 million.